PHI-501, a dual inhibitor of RAF and DDR1/2, overcomes MAPK drug resistance in Melanoma.

Cancer Cell Int · 2026 · PMC13063777 · PMID 41935307

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

did not reach statistical significancep = 0.076so close (0.05 < p ≤ 0.1)

showed a trendp = 0.076so close (0.05 < p ≤ 0.1)

In contrast, although high DDR1 expression showed a trend toward poorer survival, this association did not reach statistical significance (HR = 1.1, p = 0.076) (Fig. 2 a).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.